GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET 2019-2028

Lifesciences | Medical Devices & Consumables

GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET 2019-2028

Market By Application, Modality And Region | Forecast 2019-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

The detailed analysis of the global extra corporeal membrane oxygenation (ECMO) system market by Triton Market Research shows that, in terms of revenue, the industry is estimated to grow at a CAGR of 4.81% during the forecasting years 2019-2028. The market that was valued at $293.23 million in 2019 is likely to generate $447.55 million by 2028.

Extra corporeal membrane oxygenation is a technique of an extra corporeal technique for providing protracted respiratory and cardiac support to individuals whose lungs and heart are unable to provide an acceptable amount of perfusion to sustain life. A significant number of patients develop acute respiratory distress syndrome (ARDS). The World Health Organization (WHO) and several governments have established interim guidelines for the treatment of ARDS during COVID-19.



Report scope can be customized per your requirements. Request For Customization

An extra corporeal membrane oxygenation (ECMO) system is a device that comprises a cannula, membrane oxygenator, centrifugal pump, heat exchanger, venous reservoir, oxygen blender and post membrane pressure monitor used during cardiac & respiratory surgeries. The prevalence of cardiovascular disease is primarily driving the market growth. Older people with underlying medical difficulties like diabetes, chronic respiratory disease, cardiovascular disease and cancer are more likely to develop the serious ailment.

The study aims to get an overview of the extra corporeal membrane oxygenation (ECMO) system market in terms of various factors. Within this report, the key insights and the market definition regarding the extra corporeal membrane oxygenation (ECMO) system market have been discussed. Also, the ECMO system market and its COVID-19 impact, Porter's five forces model, market attractiveness index and vendor scorecard, have been studied in detail.

The growing popularity of the ECMO technology and the increasing prevalence of chronic disorders are the factors driving the extra corporeal membrane oxygenation (ECMO) system market progress. However, the industry is facing market restraints like the high cost of the ECMO system and the existence of alternative techniques. Key opportunities like growing awareness regarding the applications of ECMO systems and advancement in technology can be leveraged by the industry to reach the anticipated growth. However, the lack of specialized skills for operation and risks associated with ECMO procedures are some challenges faced by this market.



Geographies covered in the global extra corporeal membrane oxygenation (ECMO) system market are:

           North America: Canada and United States

           Europe: Germany, United Kingdom, Russia, Spain, Italy, France, and Rest of Europe

           Asia-Pacific: Japan, China, India, South Korea, ASEAN countries, New Zealand & Australia and Rest of Asia-Pacific

           Latin America: Mexico, Brazil and Rest of Latin America

           Middle East and Africa: South Africa, Turkey, Saudi Arabia, United Arab Emirates and Rest of Middle East & Africa

The extra corporeal membrane oxygenation (ECMO) system market has been segmented as follows:

           By Application

O         Respiratory

O         Extracorporeal cardiopulmonary resuscitation (ECPR)

O         Cardiac

           By Modality

O         Veno-Arterial

O         Veno-Venous

O         Other Modalities

The key players engaged in the extra corporeal membrane oxygenation (ECMO) system market are Eurosets, OriGen Biomedical Inc, Elsius Biomedical Inc, Terumo Medical Corporation, Abbott Laboratories, Medtronic Plc, Xenios AG (Fresenius SE & Co KGaA), LivaNova Plc, Getinge AB, Spectrum Medical, Hemovent GmbH, ALung Technologies Inc, MicroPort Scientific Corporation and Nipro Corporation. The strategic analysis for each of these companies has been covered in detail. The extra corporeal membrane oxygenation (ECMO) system market by company profile helps to dive into the data about the key market players in this industry.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. PORTER’S FIVE FORCES MODEL

2.2.1.   THREAT OF NEW ENTRANTS

2.2.2.   THREAT OF SUBSTITUTE PRODUCTS

2.2.3.   BARGAINING POWER OF BUYERS

2.2.4.   BARGAINING POWER OF SUPPLIERS

2.2.5.   COMPETITIVE RIVALRY

2.3. IMPACT OF COVID-19 ON ECMO SYSTEM MARKET

2.4. MARKET ATTRACTIVENESS INDEX

2.5. VENDOR SCORECARD

2.6. KEY INSIGHTS

2.7. MARKET DRIVERS

2.7.1.   RISING POPULARITY OF ECMO TECHNOLOGY

2.7.2.   INCREASING PREVALENCE OF CHRONIC DISORDERS

2.8. MARKET RESTRAINTS

2.8.1.   SIGNIFICANT COST OF ECMO SYSTEMS

2.8.2.   EXISTENCE OF ALTERNATIVE TECHNIQUES

2.9. MARKET OPPORTUNITIES

2.9.1.   GROWING AWARENESS REGARDING APPLICATIONS OF ECMO SYSTEMS

2.9.2.   ADVANCEMENT IN TECHNOLOGY

2.10. MARKET CHALLENGES

2.10.1.  LACK OF SPECIALIZED SKILLS FOR OPERATION

2.10.2.  RISKS ASSOCIATED WITH ECMO PROCEDURES

3.    EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET OUTLOOK - BY APPLICATION

3.1. RESPIRATORY

3.2. CARDIAC

3.3. EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR)

4.    EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET OUTLOOK - BY MODALITY

4.1. VENO-VENOUS

4.2. VENO-ARTERIAL

4.3. OTHER MODALITIES

5.    EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET – REGIONAL OUTLOOK

5.1. NORTH AMERICA

5.1.1.   MARKET BY MODALITY

5.1.2.   MARKET BY APPLICATION

5.1.3.   COUNTRY ANALYSIS

5.1.3.1.      THE UNITED STATES

5.1.3.2.      CANADA

5.2. EUROPE

5.2.1.   MARKET BY MODALITY

5.2.2.   MARKET BY APPLICATION

5.2.3.   COUNTRY ANALYSIS

5.2.3.1.      UNITED KINGDOM

5.2.3.2.      GERMANY

5.2.3.3.      FRANCE

5.2.3.4.      ITALY

5.2.3.5.      RUSSIA

5.2.3.6.      SPAIN

5.2.3.7.      REST OF EUROPE

5.3. ASIA-PACIFIC

5.3.1.   MARKET BY MODALITY

5.3.2.   MARKET BY APPLICATION

5.3.3.   COUNTRY ANALYSIS

5.3.3.1.      CHINA

5.3.3.2.      JAPAN

5.3.3.3.      INDIA

5.3.3.4.      AUSTRALIA & NEW ZEALAND

5.3.3.5.      SOUTH KOREA

5.3.3.6.      ASEAN COUNTRIES

5.3.3.7.      REST OF ASIA-PACIFIC

5.4. LATIN AMERICA

5.4.1.   MARKET BY MODALITY

5.4.2.   MARKET BY APPLICATION

5.4.3.   COUNTRY ANALYSIS

5.4.3.1.      BRAZIL

5.4.3.2.      MEXICO

5.4.3.3.      REST OF LATIN AMERICA

5.5. MIDDLE EAST AND AFRICA

5.5.1.   MARKET BY MODALITY

5.5.2.   MARKET BY APPLICATION

5.5.3.   COUNTRY ANALYSIS

5.5.3.1.      SAUDI ARABIA

5.5.3.2.      TURKEY

5.5.3.3.      UNITED ARAB EMIRATES

5.5.3.4.      SOUTH AFRICA

5.5.3.5.      REST OF MIDDLE EAST & AFRICA

6.    COMPANY PROFILES

6.1. HEMOVENT GMBH

6.2. LIVANOVA PLC

6.3. MICROPORT SCIENTIFIC CORPORATION

6.4. TERUMO MEDICAL CORPORATION

6.5. ELSIUS BIOMEDICAL INC

6.6. ABBOTT LABORATORIES

6.7. ALUNG TECHNOLOGIES INC

6.8. EUROSETS

6.9. SPECTRUM MEDICAL

6.10.  XENIOS AG (FRESENIUS SE & CO KGAA)

6.11.  MEDTRONIC PLC

6.12. GETINGE AB

6.13.  NIPRO CORPORATION

6.14.  ORIGEN BIOMEDICAL INC

7.    RESEARCH METHODOLOGY & SCOPE

7.1. RESEARCH SCOPE & DELIVERABLES

7.1.1.   OBJECTIVES OF STUDY

7.1.2.   SCOPE OF STUDY

7.2. SOURCES OF DATA

7.2.1.   PRIMARY DATA SOURCES

7.2.2.   SECONDARY DATA SOURCES

7.3. RESEARCH METHODOLOGY

7.3.1.   EVALUATION OF PROPOSED MARKET

7.3.2.   IDENTIFICATION OF DATA SOURCES

7.3.3.   ASSESSMENT OF MARKET DETERMINANTS

7.3.4.   DATA COLLECTION

7.3.5.   DATA VALIDATION & ANALYSIS

List of table

TABLE 1        GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY REGION, 2019-2028 ($ MILLION)

TABLE 2        VENDOR SCORECARD

TABLE 3        GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY APPLICATION, 2019-2028 ($ MILLION)

TABLE 4        GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY MODALITY, 2019-2028 ($ MILLION)

TABLE 5        GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY REGION, 2019-2028 ($ MILLION)

TABLE 6        NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY APPLICATION, 2019-2028 ($ MILLION)

TABLE 7        NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY MODALITY, 2019-2028 ($ MILLION)

TABLE 8        NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY COUNTRY, 2019-2028 ($ MILLION)

TABLE 9        EUROPE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY APPLICATION, 2019-2028 ($ MILLION)

TABLE 10      EUROPE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY MODALITY, 2019-2028 ($ MILLION)

TABLE 11      EUROPE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY COUNTRY, 2019-2028 ($ MILLION)

TABLE 12      ASIA-PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY APPLICATION, 2019-2028 ($ MILLION)

TABLE 13      ASIA-PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY MODALITY, 2019-2028 ($ MILLION)

TABLE 14      ASIA-PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY COUNTRY, 2019-2028 ($ MILLION)

TABLE 15      LATIN AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY APPLICATION, 2019-2028 ($ MILLION)

TABLE 16      LATIN AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY MODALITY, 2019-2028 ($ MILLION)

TABLE 17      LATIN AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY COUNTRY, 2019-2028 ($ MILLION)

TABLE 18      MIDDLE EAST AND AFRICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY APPLICATION, 2019-2028 ($ MILLION)

TABLE 19      MIDDLE EAST AND AFRICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY MODALITY, 2019-2028 ($ MILLION)

TABLE 20      MIDDLE EAST AND AFRICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY COUNTRY, 2019-2028 ($ MILLION)

List of Figures

FIGURE 1      GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET 2019-2028 ($ MILLION)

FIGURE 2      LIST OF CHRONIC DISEASES

FIGURE 3      GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY RESPIRATORY, 2019-2028 ($ MILLION)

FIGURE 4      GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY CARDIAC, 2019-2028 ($ MILLION)

FIGURE 5      GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR), 2019-2028 ($ MILLION)

FIGURE 6      GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY VENO-VENOUS, 2019-2028 ($ MILLION)

FIGURE 7      GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY VENO-ARTERIAL, 2019-2028 ($ MILLION)

FIGURE 8      GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY OTHER MODALITIES, 2019-2028 ($ MILLION)

FIGURE 9      UNITED STATES EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET 2019-2028 ($ MILLION)

FIGURE 10   CANADA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET 2019-2028 ($ MILLION)

FIGURE 11   UNITED KINGDOM EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET 2019-2028 ($ MILLION)

FIGURE 12   GERMANY EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET 2019-2028 ($ MILLION)

FIGURE 13   FRANCE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET 2019-2028 ($ MILLION)

FIGURE 14   ITALY EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET 2019-2028 ($ MILLION)

FIGURE 15   RUSSIA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET 2019-2028 ($ MILLION)

FIGURE 16   SPAIN EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET 2019-2028 ($ MILLION)

FIGURE 17   REST OF EUROPE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET 2019-2028 ($ MILLION)

FIGURE 18   CHINA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET 2019-2028 ($ MILLION)

FIGURE 19   JAPAN EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET 2019-2028 ($ MILLION)

FIGURE 20   INDIA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET 2019-2028 ($ MILLION)

FIGURE 21   AUSTRALIA & NEW ZEALAND EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET 2019-2028 ($ MILLION)

FIGURE 22   SOUTH KOREA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET 2019-2028 ($ MILLION)

FIGURE 23   ASEAN COUNTRIES EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET 2019-2028 ($ MILLION)

FIGURE 24   REST OF ASIA-PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET 2019-2028 ($ MILLION)

FIGURE 25   BRAZIL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET 2019-2028 ($ MILLION)

FIGURE 26   MEXICO EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET 2019-2028 ($ MILLION)

FIGURE 27   REST OF LATIN AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET 2019-2028 ($ MILLION)

FIGURE 28   SAUDI ARABIA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET 2019-2028 ($ MILLION)

FIGURE 29   TURKEY EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET 2019-2028 ($ MILLION)

FIGURE 30   UNITED ARAB EMIRATES EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET 2019-2028 ($ MILLION)

FIGURE 31   SOUTH AFRICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET 2019-2028 ($ MILLION)

FIGURE 32   REST OF MIDDLE EAST & AFRICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET 2019-2028 ($ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$2,750.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$4,000.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;